Rethinking Trial Access in Lower-Income Regions
Expanding breast cancer research leadership beyond high-income countries can be achieved through technology and mindset shifts, building more inclusive global trial networks.
Gen Li, PhD, MBA, president of Phesi, discussed results from the company's analysis on global inequity in breast cancer development, highlighting the geographic concentration of breast cancer trial leaders in the US and China.
Operational barriers in lower-income countries are attributed to traditional business models, with opportunities to implement a more patient-centric approach by leveraging artificial intelligence (AI) and machine learning.
- Identifying local leaders to address the lack of local KOLs in underserved areas.
- Redistributing trial workloads and improving recruitment by using AI to identify and activate new sites.
Author's summary: Technology can help expand breast cancer research.
More News
- Step-by-Step Guide To Custom Tax Return Folders - Canyon News
- Nvidia becomes first public company worth $5 trillion | TechCrunch
- 7 basic science discoveries that changed the world
- The ECHR: legal and political fault lines
- The Grateful Dead: 50 for 50 (at 60)
- 'Putin's Pet!' Nigel Farage Heckled Repeatedly While Proposing ECHR Withdrawal In Commons
- Afghanistan News Today – Breaking News, Politics, Sports & Live Updates | Ariana News
- What Is This ‘Bird Theory’ Trend Going Viral on TikTok?
- ‘TPL race to Gold Masters Tourney 2025’ to empower young talent across the nation
- SNAP Benefits to Halt on Nov 1 as Shutdown Threatens to Deepen Food Crisis in Sacramento